Toward 2030: Collaborative Solutions for Hepatitis C Diagnosis, Care, and Elimination
Nov
10
2025
Convention Center: Ballroom C, Level 3
5:00 PM
- 6:30 PM
World Class Speakers
Description
This session presents innovative and collaborative approaches to achieving global Hepatitis C elimination for adults and children. Presenters will share insights on diagnostic strategies, care linkage, and progress toward the WHO 2030 targets, highlighting efforts across clinical, public health, and global contexts.Journey Maps
Presentations
5:00 PM
- 5:15 PM
May
18
2026
Washington, D.C.
How collaborative working will achieve the WHO Target -to eliminate Hepatitis C Virus (HCV) in children and young people by 2030
Deirdre A Kelly, MD, FAASLD
, Abstract Presenter
Hepatitis
5:15 PM
- 5:30 PM
May
18
2026
Washington, D.C.
Impact of real-world hepatitis C virus antibody testing modalities across different community and clinical settings on effective linkage to care
Scott J. Cotler, MD, MD, FAASLD
, Abstract Presenter
Hepatitis
5:30 PM
- 5:45 PM
May
18
2026
Washington, D.C.
Point-of-Care HCV RNA Testing in Street Medicine: Advancing Patient Engagement and Medicaid Policy in Kentucky, USA
Gia Landry, MD, MPH
, Abstract Presenter
Hepatitis
Objectives
- Describe innovative strategies and technologies that enhance HCV testing, diagnosis, and linkage to care across diverse populations and settings.
- Discuss the role of cross-sector collaboration and global monitoring frameworks in advancing the WHO goal of HCV elimination by 2030.
- Describe partnerships between healthcare systems, community organizations, and international coalitions.
- Identify barriers and opportunities in achieving HCV elimination among children, youth, and underserved communities.